Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 568-569.
DOI: 10.19803/j.1672-8629.2019.09.10
Previous Articles Next Articles
ZHU Kouzhu, CHEN Yanhua, HONG Yuan
Received:2019-01-16
Revised:2019-10-21
Online:2019-09-20
Published:2019-10-21
CLC Number:
ZHU Kouzhu, CHEN Yanhua, HONG Yuan. One Case of Severe Drug Eruption Induced by Piperacillin Sodium and Tazobactam for Injection in Children[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 568-569.
| [1] 张浩川,王爱和,赵一鸣,等. 小儿先天性胆总管囊肿胆汁细菌培养及药敏分析[J]. 中华医院感染学杂志,2011,21(6):1 265-1 267. [2] 李婵娟. 奥美拉唑致多形性红斑一例[J]. 山西医药杂志(下半月刊),2011,(3):276. [3] 杨澍,崔艳丽,高秀清,等. β-内酰胺酶抑制剂复合制剂的不良反应文献分析[J]. 现代药物与临床,2016,31(1):106-110. [4] 毛孝钢,周华, 张媛媛, 等. β-内酰胺类抗菌药物致药物热的研究[J]. 中国现代应用药学,2016,33(6):822-824. [5] Naranjo C A,Busto U,Selters E M,et al.A method for estimating the probability of adverse drug reactions[J].Clinical Pharmacology & Therapeutics,1981,30(2):239-245. [6] Pereira F A,Mudgil A V,Rosmarin D M.Toxic epidermal necrolysis[J].Journal of the American Academy of Dermatology,2007,56(2):181-195 [7] 金伯泉. 医学免疫学[M].北京:人民卫生出版社,2008:185-186. [8] 张文竹,张媛媛,赵艳. 哌拉西林钠他唑巴坦钠致小儿渗出性多形红斑型药疹[J]. 药物不良反应杂志,2016,18(2):137-138. [9] 刘立立,黄玲,胡正波,等. 哌拉西林钠他唑巴坦钠致大疱表皮松解型药疹1例[J]. 中国药物警戒,2013,10(11):703-704. [10] 李黎. 警惕哌拉西林他唑巴坦引起的迟发型过敏反应[J].临床医药文献电子杂志,2016,3(30):6100. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
